Aldose reductase inhibition properties of novel thiazolidin-2,4-diones: In vitro and in silico approach for the treatment of diabetes-related complications
Feyzi Sinan Tokalı(Kafkas University), Fahri Akbaş(Bezmiâlem Vakıf Üniversitesi), Şeyma Ateşoğlu(Biotechnology Institute), Halil Şenol, Yeliz Demir(Ardahan University), Pelin Tokalı(Kafkas University), Furkan Çakır(Bezmiâlem Vakıf Üniversitesi)
Cited by 29
Related Papers
Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors
|Archiv der Pharmazie|2021|280
Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors
|Molecular Diversity|2022|89
Determination of the inhibition profiles of pyrazolyl–thiazole derivatives against aldose reductase and α‐glycosidase and molecular docking studies
|Archiv der Pharmazie|2020|82